Creative Biolabs
Excellence in Custom Biotechnology and Pharmaceutical Services

Creative Biolabs, a biomedical research provider, is committed to providing state-of-the-art tools and products to advance neuroscience research.

New York - The continuous emergence of innovative technologies in the field of neuroscience research presents unprecedented opportunities for deepening the understanding of neurological diseases.

Creative Biolabs flagship products are multidimensionally advancing neuroscience research.

In neurodegenerative disorder research, the Tau monoclonal antibody [https://neuros.creative-biolabs.com/tau-monoclonal-antibody-at120-ht7-and-bt2-clone-40845.htm] is a versatile research tool with various applications due to its specific targeting of tau proteins.

This innovative product helps researchers delve deeper into the role of tau proteins in neurodegenerative diseases, facilitating the development of novel therapies. "It not only offers potential for targeted therapy but also provides a powerful tool to better understand the complex mechanisms of tau proteins in neurodegenerative diseases."

Human Astrocytes: Key Cells Supporting Neuronal Health

"Human astrocytes [https://neuros.creative-biolabs.com/normal-human-astrocytes-12330.htm] are crucial tools for studying brain health and diseases," said the expert. "These cell models allow us to simulate realistic cellular environments in the lab, revealing complex interactions between neurons and glial cells."

Creative Biolabs' human astrocytes provide an ideal cellular model for researchers to study interactions between neurons and glial cells. These cells reflect mechanisms supporting neurons, neuroinflammatory responses, and changes in neurological diseases, offering new insights for disease research projects.

HMC3 Cells: Revealing Neuroimmune Mechanisms

For studying immune responses, Creative Biolabs offers valuable tools such as the human microglial cell line, HMC3 cells [https://neuros.creative-biolabs.com/human-microglia-cell-line-hmc3-immortalized-44105.htm]. These cells are used to study immune surveillance and the phagocytic functions of microglia, which are pivotal in researching neuroinflammation and neurodegenerative diseases.

"The HMC3 cell line is a robust tool. As primary immune cells in the brain, understanding their function allows us to study neuroinflammatory processes in detail and their roles in diseases."

Cerebral Organoids: 3D Tools for Mimicking Brain Development

The advent of cerebral organoid technology revolutionizes the ability to study brain development and function in vitro. Building on this, Creative Biolabs has developed cerebral organoid maturation kits [https://neuros.creative-biolabs.com/neuroinduc-cerebral-organoid-maturation-kit-human-12413.htm], optimizing and accelerating organoid maturation closer to the structure and function of real brains using serum-free cell culture media. This tool is applicable for studying brain development, constructing models of neurological diseases, and drug screening.

"We can create tissue models in the lab that closely resemble human brain tissue, aiding research into brain development and providing a crucial platform for studying neurological diseases and drug development."

Creative Biolabs offers a comprehensive research toolbox, from cells to organoids, supporting neuroscience research through various technological pathways.

Shirley, NY, : Advances in gut diseases, like malignant colorectal cancer, have seen a huge surge, with more evidence confirming the protective effect of probiotics, both in maintaining a stable, healthy gut microbiota and deducing the risk of disease onsite. Creative Biolabs is at the vanguard of the stream of live biotherapeutics (LBP). Their work spans not only the intricate interactions between the gut microbiome and disease but also LBP development, starting with bacteria identification and extending to comprehensive safety, efficacy, and stability analyses, aiming to harness beneficial microbes to inhibit tumor growth and enhance the efficacy of existing therapies.



Lactobacillus gasseri as Next Generation Probiotics



Lactobacillus gasseri, a probiotic known for its beneficial effects on gut health, has been shown to play a critical role in maintaining a balanced microbiome and supporting immune function.



"In previous projects we have evaluated the probiotic activity of L. gasseri based on the availability of genome sequence and species-specific adaptability to human mucosa. L. gasseri obtains various health benefits through its antibacterial activity, bacteriocin production, and immune regulation of the innate and adaptive systems in humans." -According to a scientist at Creative Biolabs.



Lactobacillus plantarum for Therapeutic Applications



Creative Biolabs also specializes in exploiting Lactobacillus plantarum (L. plantarum), a versatile probiotic having the ability to endure in various environments and its robust probiotic properties, for therapeutic applications. Their solutions focus on the potential of L. plantarum to support digestive health, enhance immune responses, and prevent infections.



"We've collected several L. plantarum products, like powder, cells, and bacteria, to meet diverse research needs." The scientist elaborated.



Advancing Bifidobacterium longum Research



Bifidobacterium longum (B. longum) is another key area of research known for maintaining gut health, supporting digestion, and modulating the immune system. Creative Biolabs assists in the exploration of B. longum's as therapies, particularly in the context of gastrointestinal disorders and immune-related conditions, especially cancer, since B. longum selectively locates and proliferates in solid tumors after systemic application, thus making it optimal for tumor-specific gene delivery and enzyme prodrug therapy.



Innovative Enterococcus faecalis as Therapeutic Candidates



Enterococcus faecalis (E. faecalis), often associated with infections like inflammatory bowel disease, has promising therapeutic applications that Creative Biolabs is keen to explore through the most efficient E. faecalis-based NGP discovery approach.



"We have developed a wide range of NGPs promising for targeted therapy for gut diseases, and our list is growing. But simply identifying new ones is far from enough. We encourage that future probiotic formulations should include sources of isolation, taking into account genetic and phenotypic characteristics, for use in different body parts." The scientist concluded.

Creative Biolabs, a leading service provider in the life sciences field, is excited to present its comprehensive range of classical complement products designed to support researchers in exploring the complex complement system.

New York, USA - August 12, 2024 - The complement system has garnered attention for its critical role in immune responses and various diseases. Complement proteins [https://www.creative-biolabs.com/complement-therapeutics/category-proteins-44.htm] are central to understanding the function of this system and its involvement in diseases. Creative Biolabs offers a variety of high-quality complement proteins, including the essential C1q protein, which is vital for research into the classical complement pathway.

Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg

Complement Proteins

"C1q is a key component of the complement cascade. Together with C1r and C1s, it forms the C1 complex, initiating the classical complement pathway. Our C1q protein products are meticulously purified and characterized to ensure high activity and reliability across various experiments," said the Chief Scientist at Creative Biolabs.

Some other types of protein products are also recommended by Creative Biolabs, such as C1 complex, C3, C4b binding protein, C5, etc.

Below are some available protein products:

- C1 Complex: Native Human Complement C1 Complex Protein

- C3: Recombinant Human Complement C3 Protein-GST tag

- C4b Binding Protein: Recombinant Mouse C4bp Protein

- C5: Native Human Complement C5 Protein

"In addition to individual complement proteins, our platform also includes inhibitors and activators that can be used to study their effects on the complement cascade," the Chief Scientist added.

Assay Kits

Assay kits are crucial tools for quantifying complement components and assessing their functional status. Creative Biolabs offers high-sensitivity ELISA kits to measure complement levels and activity, ensuring accuracy and reliability in research results.

"Our Mouse Complement C1q ELISA [https://www.creative-biolabs.com/complement-therapeutics/mouse-complement-c1q-elisa-kit-781.htm] Kit is specifically designed for measuring C1q levels in mouse plasma and serum. This kit offers high sensitivity, detecting C1q as low as 0.244 ng/mL," the scientist noted.

The complement platform also features the classical CH50 functional test kit [https://www.creative-biolabs.com/complement-therapeutics/ch50-functional-test-kit-4501.htm]. "This kit assesses complement activity by measuring the ability of serum to lyse antibody-coated sheep red blood cells (SRBC). It helps identify complement activity levels and detect defects or functional abnormalities in the complement pathway."

Serum and Plasma

High-quality biological samples are often required for complement system research. Creative Biolabs provides human complement plasma and serum that are carefully processed and stored to maintain complement activity and integrity.

"For instance, our pooled complement plasma [https://www.creative-biolabs.com/complement-therapeutics/human-complement-plasma-pooled-1767.htm] is prepared from fresh whole blood and then frozen at -80 degrees C to preserve complement activity," the scientist explained. This plasma is suitable for hemolytic plaque assays, complement fixation assays, and other lymphocyte toxicity and hemolysis procedures. Freezing prevents complement degradation, ensuring consistency and reliability in research.

"We also offer high-quality human serum, ideal for assays requiring a stable matrix, such as analyzing complement components and other biomarkers. Our serum products undergo rigorous processing and storage to maintain the highest quality and reliability."

In addition to the products mentioned, Creative Biolabs' comprehensive complement system offerings include inhibitors, peptides, and aptamer-related products.

These support a wide range of research needs:

- Basic Research: Exploring the fundamental mechanisms and regulation of the complement system.

- Disease Research: Investigating the role of the complement system in various diseases, including autoimmune diseases, infections, and cancers.

- Drug Development: Developing and testing innovative therapies to modulate complement activity.

In the fast-paced world of biotech, where innovation is the name of the game, mRNA has emerged as a powerful tool, but the challenge lies in safely and efficiently delivering these delicate mRNA molecules into cells-a task that Creative Biolabs is not only rising to but leading the charge on.

New York, USA - August 29, 2024 - "Unlike DNA plasmids, mRNA does not need to enter the nucleus to be translated into proteins, making it a faster and more efficient option. However, this simplicity comes with its own set of challenges-mainly, ensuring that the mRNA is delivered into the cytoplasm without being degraded," according to a scientist at Creative Biolabs, "and this is where Creative Biolabs steps in, supporting researchers to overcome these challenges by developing and optimizing various delivery vehicles for mRNA [https://mrna.creative-biolabs.com/custom-delivery-vehicle-for-mrna.htm]."



Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg



One of the most talked-about methods in recent years is the use of lipid nanoparticles [https://mrna.creative-biolabs.com/lipid-nanoparticle.htm] (LNPs). Unlike traditional cationic lipids, which have raised concerns due to their toxicity, LNPs are gaining traction as a safer, more efficient alternative. Creative Biolabs has been at the forefront of developing LNPs that not only protect mRNA from degradation but also ensure its delivery into the cytoplasm, where it can do its work, which is crucial in applications like CRISPR-Cas9 gene editing, where transient expression is key to minimizing off-target effects.



A scientist from Creative Biolabs explains, "The use of LNPs in mRNA delivery is revolutionizing the field. Our services not only include the design and optimization of these nanoparticles but also extend to the development of customized delivery vehicles tailored to specific research needs. We understand that one size doesn't fit all, so we work closely with our clients to develop solutions that are as unique as their research objectives."



Another exciting application of mRNA technology is in the development of vaccines. With the unprecedented success of mRNA-based COVID-19 vaccines, their potential in preventing other diseases has never been clearer. In addition to LNPs, exosome-like virus-like particle (eVLP) delivery systems for mRNA [https://mrna.creative-biolabs.com/evlp.htm] provide a novel approach to mRNA vaccine delivery. Creative Biolabs customizes various types of eVLPs to deliver proteins, tRNAs, rRNAs, and mRNAs, including lentivirus-like particles (LVLPs), murine leukemia virus-like particles (MLVPs), Venezuelan equine encephalitis virus-like particles (VEEVLPs), and mammalian retrovirus-like particles (PEG10-VLPs), which not only guarantee enhanced transfection efficiency but also the mRNA integrity, contributing to the development of next-generation vaccines and gene therapies.